These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 13634180)

  • 21. [Research on the kinetics of inactivating Escherichia coli phages T1 & T5 with protamine].
    SIEFERT-GRETCHMAN G; KAPLAN RW
    Arch Mikrobiol; 1958; 30(4):363-82. PubMed ID: 13595816
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of gamma irradiation on bacteriophages used as viral indicators.
    Jebri S; Hmaied F; Jofre J; MariemYahya ; Mendez J; Barkallah I; Hamdi M
    Water Res; 2013 Jul; 47(11):3673-8. PubMed ID: 23726703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bacteriophage treatment of a severe Escherichia coli respiratory infection in broiler chickens.
    Huff WE; Huff GR; Rath NC; Balog JM; Donoghue AM
    Avian Dis; 2003; 47(4):1399-405. PubMed ID: 14708988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The stability of bacterial viruses in solutions of salts.
    ADAMS MH
    J Gen Physiol; 1949 May; 32(5):579-94. PubMed ID: 18131256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. THE ISOLATION OF COLI-DYSENTERY BACTERIOPHAGES AND THEIR CORRELATION TO THE T PHAGES OF ESCHERICHIA COLI "B".
    BECKER EF; ROBBINS ML
    J Baltimore Coll Dent Surg; 1965 May; 20():5-14. PubMed ID: 14315823
    [No Abstract]   [Full Text] [Related]  

  • 26. Associations among Antibiotic and Phage Resistance Phenotypes in Natural and Clinical
    Allen RC; Pfrunder-Cardozo KR; Meinel D; Egli A; Hall AR
    mBio; 2017 Oct; 8(5):. PubMed ID: 29089428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Developing and optimizing bacteriophage treatment to control enterohemorrhagic Escherichia coli on fresh produce.
    Snyder AB; Perry JJ; Yousef AE
    Int J Food Microbiol; 2016 Nov; 236():90-7. PubMed ID: 27454784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Spheroplasts of Escherichia coli obtained by means of phage "ghosts"].
    GOL'DFARB DM; AVDEEVA AV; BORISOVA NB
    Mikrobiologiia; 1962; 31():869-79. PubMed ID: 13963331
    [No Abstract]   [Full Text] [Related]  

  • 29. [Genetic analysis of phi 80 bacteriophage by superinfection with transducer phage phi 80 trp in defective lysogenic strains of E. coli].
    Gratia JP
    Ann Inst Pasteur (Paris); 1971 Feb; 120(2):121-5. PubMed ID: 4929653
    [No Abstract]   [Full Text] [Related]  

  • 30. Computational determination of the effects of virulent Escherichia coli and salmonella bacteriophages on human gut.
    Mostafa MM; Nassef M; Badr A
    Comput Methods Programs Biomed; 2016 Oct; 135():27-35. PubMed ID: 27586477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on the relationship between virus and host cell. III. The breakdown of P32 labelled T2r+ bacteriophage adsorbed to E. coli previously infected by other coliphages of the T group.
    FRENCH RC; LESLEY SM; GRAHAM AF; van ROOYEN CE
    Can J Med Sci; 1951 Jun; 29(3):144-8. PubMed ID: 14839569
    [No Abstract]   [Full Text] [Related]  

  • 32. Selective inhibition of the multiplication of phage Tl in E. coli K12.
    DI MARCO A; GHIONE M; SANFILIPPO A; MORVILLO E
    Experientia; 1963 Mar; 19():134-6. PubMed ID: 14027564
    [No Abstract]   [Full Text] [Related]  

  • 33. Infectious nucleic acids of Escherichia coli bacteriophages. 10. Preparation and properties of Escherichia coli competent for infectious DNA from bacteriophages phi X 174 and M 13 and RNA from bacteriophage M 12.
    Benzinger R; Delius H; Janenisch R; Hofschneider PH
    Eur J Biochem; 1967 Nov; 2(4):414-28. PubMed ID: 4965950
    [No Abstract]   [Full Text] [Related]  

  • 34. Emergence of biofilm-forming subpopulations upon exposure of Escherichia coli to environmental bacteriophages.
    Lacqua A; Wanner O; Colangelo T; Martinotti MG; Landini P
    Appl Environ Microbiol; 2006 Jan; 72(1):956-9. PubMed ID: 16391144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [On the release of their bacteriophage and antibiotics by various types of both lysogenic and colicinogenic E. coli].
    HAMON Y; PERON Y
    Arch Roum Pathol Exp Microbiol; 1962 Jun; 21():342-50. PubMed ID: 13952420
    [No Abstract]   [Full Text] [Related]  

  • 36. Increased fragility of Escherichia coli after infection with bacteriophage M13.
    Roy A; Mitra S
    J Virol; 1970 Sep; 6(3):333-9. PubMed ID: 4921123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic studies on T2 Escherichia coli bacteriophage.
    AJL SJ
    J Bacteriol; 1950 Oct; 60(4):393-9. PubMed ID: 14784467
    [No Abstract]   [Full Text] [Related]  

  • 38. The influence of the host character of E. coli upon its lysis by bacteriophage. II. The influence of host character on the acriflavine tolerance of bacteriophage T3.
    HOSHINO T
    Jpn J Exp Med; 1954 Apr; 24(2):63-8. PubMed ID: 13221351
    [No Abstract]   [Full Text] [Related]  

  • 39. SOME RESULTS OF PHAGE SUPERINFECTION DURING THYMINELESS INDUCTION OF ESCHERICHIA COLI K12(LAMBDA)THY-.
    KORN D
    Virology; 1964 Jul; 23():438-41. PubMed ID: 14194143
    [No Abstract]   [Full Text] [Related]  

  • 40. INDUCIBLE PHAGE OF ESCHERICHIA COLI 15.
    ENDO H; AYABE K; AMAKO K; TAKEYA K
    Virology; 1965 Mar; 25():469-71. PubMed ID: 14328616
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.